Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?

Anaerobic bacteria have pivotal roles in the microbiota of humans and they are significant infectious agents involved in many pathological processes, both in immunocompetent and immunocompromised individuals. Their isolation, cultivation and correct identification differs significantly from the work...

Full description

Saved in:
Bibliographic Details
Main Authors: Márió Gajdács (Author), Gabriella Spengler (Author), Edit Urbán (Author)
Format: Book
Published: MDPI AG, 2017-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ff3e181ae4ad41c29e8cb9b85cec6a2e
042 |a dc 
100 1 0 |a Márió Gajdács  |e author 
700 1 0 |a Gabriella Spengler  |e author 
700 1 0 |a Edit Urbán  |e author 
245 0 0 |a Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology? 
260 |b MDPI AG,   |c 2017-11-01T00:00:00Z. 
500 |a 2079-6382 
500 |a 10.3390/antibiotics6040025 
520 |a Anaerobic bacteria have pivotal roles in the microbiota of humans and they are significant infectious agents involved in many pathological processes, both in immunocompetent and immunocompromised individuals. Their isolation, cultivation and correct identification differs significantly from the workup of aerobic species, although the use of new technologies (e.g., matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, whole genome sequencing) changed anaerobic diagnostics dramatically. In the past, antimicrobial susceptibility of these microorganisms showed predictable patterns and empirical therapy could be safely administered but recently a steady and clear increase in the resistance for several important drugs (β-lactams, clindamycin) has been observed worldwide. For this reason, antimicrobial susceptibility testing of anaerobic isolates for surveillance purposes or otherwise is of paramount importance but the availability of these testing methods is usually limited. In this present review, our aim was to give an overview of the methods currently available for the identification (using phenotypic characteristics, biochemical testing, gas-liquid chromatography, MALDI-TOF MS and WGS) and antimicrobial susceptibility testing (agar dilution, broth microdilution, disk diffusion, gradient tests, automated systems, phenotypic and molecular resistance detection techniques) of anaerobes, when should these methods be used and what are the recent developments in resistance patterns of anaerobic bacteria. 
546 |a EN 
690 |a anaerobic bacteria 
690 |a susceptibility testing 
690 |a methodology 
690 |a antimicrobial resistance 
690 |a MALDI-TOF MS 
690 |a Bacteroides fragilis group 
690 |a Clostridium spp. taxonomy 
690 |a metronidazole 
690 |a β-lactams 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 6, Iss 4, p 25 (2017) 
787 0 |n https://www.mdpi.com/2079-6382/6/4/25 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/ff3e181ae4ad41c29e8cb9b85cec6a2e  |z Connect to this object online.